Early-life differences in the gut microbiota composition and functionality of infants at elevated likelihood of developing autism spectrum disorder
Различия в составе и функциональных свойствах кишечной микробиоты на ранних этапах жизни у детей с повышенной вероятностью развития расстройства аутистического спектра
2023-07-13
SCID: 54.1/kzw78g3e
Discuss with AI
Bifidobacteriumautism spectrum disordergamma-aminobutyric acid (GABA)gut microbiotamicrobiome-metabolome analysis
Figures from the paper
Abstract (AI)
Abstract Evidence from cross-sectional human studies, and preliminary microbial-based intervention studies, have implicated the microbiota-gut-brain axis in the neurobiology of autism spectrum disorder (ASD). Using a prospective longitudinal study design, we investigated the developmental profile of the fecal microbiota and metabolome in infants with (n = 16) and without (n = 19) a family history of ASD across the first 36 months of life. In addition, the general developmental levels of infants were evaluated using the Mullen Scales of Early Learning (MSEL) test at 5 and 36 months of age, and with ADOS-2 at 36 months of age. At 5 months of age, infants at elevated-likelihood of ASD (EL) harbored less Bifidobacterium and more Clostridium and Klebsiella species compared to the low-likelihood infants (LL). Untargeted metabolic profiling highlighted that LL infants excreted a greater amount of fecal γ-aminobutyric acid (GABA) at 5 months, which progressively declined with age. Similar age-dependent patterns were not observed in the EL group, with GABA being consistently low across all timepoints. Integrated microbiome-metabolome analysis showed a positive correlation between GABA and Bifidobacterium species and negative associations with Clostridium species. In vitro experiments supported these observations demonstrating that bifidobacteria can produce GABA while clostridia can consume it. At the behavioral level, there were no significant differences between the EL and LL groups at 5 months. However, at 36 months of age, the EL group had significantly lower MSEL and ADOS-2 scores compared to the LL group. Taken together, the present results reveal early life alterations in gut microbiota composition and functionality in infants at elevated-likelihood of ASD. These changes occur before any behavioral impairments can be detected, supporting a possible role for the gut microbiota in emerging behavioral variability later in life.
Key Findings
1
At five months, infants with elevated likelihood of ASD had fewer Bifidobacterium and more Clostridium and Klebsiella species than low-likelihood infants.
2
Fecal GABA correlated positively with Bifidobacterium and negatively with Clostridium, while in vitro experiments showed bifidobacteria produce GABA and clostridia consume it.
3
Low-likelihood infants showed higher fecal GABA levels at five months, followed by an age-related decline; elevated-likelihood infants maintained consistently low GABA levels.
4
Microbiota and GABA alterations preceded detectable behavioral differences, which emerged by 36 months as lower MSEL and ADOS-2 scores in the elevated-likelihood group.
5
The findings support a potential role for early gut microbiota composition and function in later-emerging behavioral variability associated with ASD likelihood.
Research Object
Fecal gut microbiota and metabolome in infants at elevated likelihood of developing autism spectrum disorder
Research Subject
Early-life developmental changes in microbiota composition, GABA-associated functionality, and their relationships with later neurodevelopmental outcomes
Publication Details
Publication Date
2023-07-13
Journal
Publisher
ISSN
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest